Prognosis after initial myocardial infarction: the Framingham study
- PMID: 453046
- DOI: 10.1016/0002-9149(79)90250-9
Prognosis after initial myocardial infarction: the Framingham study
Abstract
During 20 years of follow-up of 5,127 men and women initially free of coronary heart disease in the Framingham cohort, 193 men and 53 women had one or more recognized, symptomatic myocardial infarctions. An additional 45 men and 28 women had unrecognized myocardial infarctions. Subsequent mortality and morbidity including angina, reinfarction, congestive failure and sudden death were ascertained. One in five men who had a first myocardial infarction died within 1 year, a mortality rate 14 times that of those free of coronary heart disease. In men who survived the 1st year, a recognized myocardial infarction increased risk of death over the next 5 years to 23 percent, four times that of the general population. The next 5 years carried a 25 percent mortality (three times that of the general population). The prognosis was distinctly worse in women than in men chiefly because of a higher (45 percent) early mortality rate in women. Patients with recognized and unrecognized myocardial infarctions had similar survival rates after 3 years. A second myocardial infarction occurred in 13 percent of the men and in 40 percent of the women within 5 years of the first infarction. Thus, women were more prone to death and reinfarction than men. Congestive heart failure occurred as commonly as reinfarction, affliction 14 percent of the men within 5 years of the initial infarction. Once congestive failure ensued, half of the affected patients were dead within 5 years. Angina developed in one third of the patients within 5 years of their first infarction.
Similar articles
-
Prognosis after first myocardial infarction. Comparison of Q-wave and non-Q-wave myocardial infarction in the Framingham Heart Study.JAMA. 1992 Sep 23-30;268(12):1545-51. doi: 10.1001/jama.268.12.1545. JAMA. 1992. PMID: 1518109
-
Unrecognized myocardial infarction: epidemiology, clinical characteristics, and the prognostic role of angina pectoris. The Reykjavik Study.Ann Intern Med. 1995 Jan 15;122(2):96-102. doi: 10.7326/0003-4819-122-2-199501150-00003. Ann Intern Med. 1995. PMID: 7993002
-
Effect of gender on long-term outcome of angina pectoris and myocardial infarction/sudden unexpected death.JAMA. 1993 May 12;269(18):2392-7. JAMA. 1993. PMID: 8479065
-
Epidemiological aspects of heart failure.Cardiol Clin. 1989 Feb;7(1):1-9. Cardiol Clin. 1989. PMID: 2523239 Review.
-
Sudden death: lessons from subsets in population studies.J Am Coll Cardiol. 1985 Jun;5(6 Suppl):141B-149B. doi: 10.1016/s0735-1097(85)80545-3. J Am Coll Cardiol. 1985. PMID: 3889106 Review.
Cited by
-
Prognosis After First-Ever Myocardial Infarction in Type 1 Diabetes Is Strongly Affected by Chronic Kidney Disease.Diabetes Care. 2023 Jan 1;46(1):197-205. doi: 10.2337/dc22-1586. Diabetes Care. 2023. PMID: 36399763 Free PMC article.
-
Myocardial Viability: From Proof of Concept to Clinical Practice.Cardiol Res Pract. 2016;2016:1020818. doi: 10.1155/2016/1020818. Epub 2016 May 29. Cardiol Res Pract. 2016. PMID: 27313943 Free PMC article. Review.
-
Cardiac effects of angiotensin converting enzyme inhibitors.Cardiovasc Drugs Ther. 1990 Feb;4(1):243-5. doi: 10.1007/BF01857639. Cardiovasc Drugs Ther. 1990. PMID: 2285617 Review.
-
Wearable Cardioverter-Defibrillator after Myocardial Infarction.N Engl J Med. 2018 Sep 27;379(13):1205-1215. doi: 10.1056/NEJMoa1800781. N Engl J Med. 2018. PMID: 30280654 Free PMC article. Clinical Trial.
-
Proceedings from the scientific symposium: Sex differences in cardiovascular disease and implications for therapies.J Womens Health (Larchmt). 2010 Jun;19(6):1059-72. doi: 10.1089/jwh.2009.1695. J Womens Health (Larchmt). 2010. PMID: 20500123 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources